行情

CSBR

CSBR

Champions
NASDAQ

实时行情|Nasdaq Last Sale

7.24
+0.22
+3.13%
盘后: 7.24 0 0.00% 16:00 02/19 EST
开盘
7.25
昨收
7.02
最高
7.28
最低
7.06
成交量
1.71万
成交额
--
52周最高
11.94
52周最低
4.976
市值
8,413.00万
市盈率(TTM)
-84.7775
分时
5日
1月
3月
1年
5年

分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

CSBR 新闻

  • 现代汽车董事长郑梦九将于下月交棒 由长子继任
  • 新浪财经综合.13分钟前
  • 美国华裔男子操纵数字货币骗局 骗了1.47亿美元
  • 新浪财经.21分钟前
  • 华盛早报 | 特斯拉涨近7%重回900美元,跟谁学股价飙升近19%
  • 华盛通.27分钟前
  • 亚马逊首位员工访谈:公司变得如此庞大 令人害怕
  • 新浪科技.34分钟前

更多

所属板块

生物技术和医学研究
+1.22%
制药与医学研究
+0.32%

热门股票

名称
价格
涨跌幅

CSBR 简况

Champions Oncology, Inc. is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. The Company has two business segments: Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). The POS segment provides physicians and patients information to help guide the development of personalized treatment plans. The TOS segment provides services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. Its TumorGraft Technology Platform consists of processes, physical tumors and information that it uses to personalize the development and use of oncology drugs. Each tumor from patients that it has preserved for implantation in mice, along with the patient data and molecular information associated with the tumors, are known as TumorGrafts or Patient Derived XenoGrafts of PDX Models. The collection of TumorGrafts is referred to as the Company's TumorBank.
展开

Webull提供Champions Oncology Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。